Vascular disease in mixed connective tissue disease (MCTD).
Kondo
H
H
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006965:Hyperplasia / Q000276:immunology; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008947:Mixed Connective Tissue Disease / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D012077:Renal Artery / Q000473:pathology*; D013256:Steroids; D016896:Treatment Outcome; D017539:Tunica Intima / Q000473:pathology; D014652:Vascular Diseases / Q000276:immunology* / Q000473:pathology
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D013256:Steroids; D003520:Cyclophosphamide